Evidence map›Paper›PMID 38019945›Full record

ArticleBioinformatics (Oxford, England)2023

Improving the filtering of false positive single nucleotide variations by combining genomic features with quality metrics.

Kazım Kıvanç Eren, Esra Çınar, Hamza U Karakurt, Arzucan Özgür

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kazım Kıvanç ErenDepartment of Computer Engineering, Kocaeli University, Kocaeli 41000, Turkey.ORCID 0000-0002-5071-2722
Esra ÇınarR&D Department, Idea Technology Solutions LLC., Istanbul 34396, Turkey.
Hamza U KarakurtR&D Department, Idea Technology Solutions LLC., Istanbul 34396, Turkey.ORCID 0000-0002-4072-3065
Arzucan ÖzgürDepartment of Computer Engineering, Boğaziçi University, Istanbul 34342, Turkey.ORCID 0000-0001-8376-1056

Funding

Scientific and Technological Research Council of Turkey TEYDEB-3190261
6 · The paper itself

Abstract

motivationTechnical errors in sequencing or bioinformatics steps and difficulties in alignment at some genomic sites result in false positive (FP) variants. Filtering based on quality metrics is a common method for detecting FP variants, but setting thresholds to reduce FP rates may reduce the number of true positive variants by overlooking the more complex relationships between features. The goal of this study is to develop a machine learning-based model for identifying FPs that integrates quality metrics with genomic features and with the feature interpretability property to provide insights into model results.

resultsWe propose a random forest-based model that utilizes genomic features to improve identification of FPs. Further examination of the features shows that the newly introduced features have an important impact on the prediction of variants misclassified by VEF, GATK-CNN, and GARFIELD, recently introduced FP detection systems. We applied cost-sensitive training to avoid errors in misclassification of true variants and developed a model that provides a robust mechanism against misclassification of true variants while increasing the prediction rate of FP variants. This model can be easily re-trained when factors such as experimental protocols might alter the FP distribution. In addition, it has an interpretability mechanism that allows users to understand the impact of features on the model's predictions. AVAILABILITY AND IMPLEMENTATION: The software implementation can be found at https://github.com/ideateknoloji/FPDetect.

Indexed as

GenomicsHigh-Throughput Nucleotide SequencingComputational BiologyGenomeSoftware

Identifiers

PMID38019945
PMCPMC10692869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.